Cynthia Oliver

Cynthia Oliver supports the Centers for Disease Control and Prevention’s Office of Acquisition Services in managing mission-critical procurement activities that enable public health surveillance, laboratory diagnostics, and biomedical research. She oversees the acquisition of specialized scientific equipment, diagnostic technologies, and data infrastructure essential to CDC’s response to infectious disease threats and public health emergencies. Her work ensures timely access to high-integrity testing systems, analytical platforms, and clinical support services that underpin national health security operations. She routinely handles complex, technical solicitations requiring stringent compliance with federal biomedical procurement standards and performance-based contract structures. Oliver maintains established relationships with key vendors including General Dynamics Information Technology, GlaxoSmithKline, MRIGLOBAL, Cepheid, and the New York City Health & Hospitals Corp. These partnerships reflect a focus on high-capacity laboratories, molecular diagnostics, and integrated health data systems. Her contracting approach emphasizes long-term vendor collaboration, performance accountability, and technical validation, particularly for products requiring FDA clearance or CLIA compliance. She engages with both large-scale prime contractors and specialized technical providers to ensure scalable, secure, and interoperable solutions across CDC’s national network. Oliver’s procurement portfolio reflects a strong preference for full and open competition, with no set-asides applied to her awarded contracts. This indicates a strategic focus on technical capability and operational readiness over socioeconomic classifications, prioritizing mission-critical performance over programmatic set-aside requirements. While small business participation is not formally incentivized in her portfolio, she adheres strictly to federal procurement integrity standards and ensures competitive fairness across all solicitation processes. Her primary procurement focus lies in NAICS categories related to testing laboratories and services, computer and peripheral equipment wholesaling, and specialized manufacturing of diagnostic and control devices. She consistently acquires advanced laboratory instrumentation, clinical data systems, and precision measurement technologies critical to infectious disease detection and public health analytics. Her expertise spans biomedical engineering, laboratory automation, and health information systems, ensuring CDC’s operational readiness through technically rigorous and compliant acquisitions.